Bristol-Myers Squibb Company (JOBS), After Nutrition Business Sale, Has New Pure Pharma Focus, $8B for Deals

Bookmark and Share

AP -- Bristol-Myers Squibb Co., the world’s No. 15 drugmaker by revenue, reports fourth-quarter earnings Thursday. The following is a summary of key developments and analyst opinion related to the period.

MORE ON THIS TOPIC